,genes,pathway,count
0,PTK2B,positive regulation of cell projection organization (GO:0031346),24
1,PTK2B,regulation of release of sequestered calcium ion into cytosol (GO:0051279),24
2,PTK2B,regulation of establishment or maintenance of cell polarity (GO:0032878),24
3,PTK2B,regulation of neurotransmitter receptor activity (GO:0099601),24
4,PTK2B,ionotropic glutamate receptor signaling pathway (GO:0035235),24
5,PTK2B,positive regulation of stress-activated MAPK cascade (GO:0032874),24
6,PTK2B,regulation of NMDA receptor activity (GO:2000310),24
7,PTK2B,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",24
8,PTK2B,regulation of calcium ion transport into cytosol (GO:0010522),24
9,PTK2B,regulation of calcium ion transmembrane transport (GO:1903169),24
10,PTK2B,positive regulation of excitatory postsynaptic potential (GO:2000463),24
11,PTK2B,cellular response to retinoic acid (GO:0071300),24
12,PTK2B,regulation of neuron projection development (GO:0010975),24
13,PTK2B,regulation of cation channel activity (GO:2001257),24
14,PTK2B,positive regulation of cytoskeleton organization (GO:0051495),24
15,PTK2B,vascular endothelial growth factor receptor signaling pathway (GO:0048010),24
16,PTK2B,positive regulation of neuron projection development (GO:0010976),24
17,PTK2B,negative regulation of biomineral tissue development (GO:0070168),24
18,PTK2B,regulation of actin cytoskeleton reorganization (GO:2000249),24
19,PTK2B,positive regulation of neuron differentiation (GO:0045666),24
20,PTK2B,regulation of glutamate receptor signaling pathway (GO:1900449),24
21,PTK2B,positive regulation of supramolecular fiber organization (GO:1902905),24
22,PTK2B,positive regulation of synaptic transmission (GO:0050806),24
23,PTK2B,regulation of establishment of cell polarity (GO:2000114),24
24,RPS19,ribosome assembly (GO:0042255),21
25,RPS19,peptide biosynthetic process (GO:0043043),21
26,RPS19,protein targeting to ER (GO:0045047),21
27,RPS19,viral gene expression (GO:0019080),21
28,RPS19,viral transcription (GO:0019083),21
29,RPS19,rRNA processing (GO:0006364),21
30,RPS19,ncRNA processing (GO:0034470),21
31,RPS19,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),21
32,RPS19,cotranslational protein targeting to membrane (GO:0006613),21
33,RPS19,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",21
34,RPS19,nuclear-transcribed mRNA catabolic process (GO:0000956),21
35,RPS19,negative regulation of immune effector process (GO:0002698),21
36,RPS19,negative regulation of innate immune response (GO:0045824),21
37,RPS19,ribosomal small subunit assembly (GO:0000028),21
38,RPS19,translation (GO:0006412),21
39,RPS19,regulation of cell development (GO:0060284),21
40,RPS19,ribosome biogenesis (GO:0042254),21
41,RPS19,defense response to bacterium (GO:0042742),21
42,RPS19,positive regulation of innate immune response (GO:0045089),21
43,RPS19,rRNA metabolic process (GO:0016072),21
44,RPS19,maturation of SSU-rRNA (GO:0030490),21
45,DMTN,lamellipodium organization (GO:0097581),19
46,DMTN,cellular response to cAMP (GO:0071320),19
47,CAV3,positive regulation of supramolecular fiber organization (GO:1902905),19
48,CAV3,cholesterol homeostasis (GO:0042632),19
49,CAV3,regulation of membrane depolarization (GO:0003254),19
50,CAV3,regulation of microtubule polymerization (GO:0031113),19
51,CAV3,plasma membrane organization (GO:0007009),19
52,DMTN,negative regulation of cell-matrix adhesion (GO:0001953),19
53,CAV3,lipid transport (GO:0006869),19
54,DMTN,regulation of filopodium assembly (GO:0051489),19
55,CAV3,negative regulation of protein kinase activity (GO:0006469),19
56,DMTN,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),19
57,DMTN,regulation of lamellipodium organization (GO:1902743),19
58,DMTN,calcium-mediated signaling (GO:0019722),19
59,DMTN,regulation of cytoskeleton organization (GO:0051493),19
60,DMTN,myeloid cell development (GO:0061515),19
61,DMTN,calcium-mediated signaling using intracellular calcium source (GO:0035584),19
62,DMTN,negative regulation of intracellular protein transport (GO:0090317),19
63,DMTN,negative regulation of cell junction assembly (GO:1901889),19
64,DMTN,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),19
65,DMTN,negative regulation of adherens junction organization (GO:1903392),19
66,DMTN,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),19
67,DMTN,negative regulation of protein localization to membrane (GO:1905476),19
68,DMTN,negative regulation of focal adhesion assembly (GO:0051895),19
69,CAV3,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),19
70,CAV3,regulation of ion transmembrane transporter activity (GO:0032412),19
71,CAV3,regulation of cytosolic calcium ion concentration (GO:0051480),19
72,DMTN,response to cAMP (GO:0051591),19
73,CAV3,organic substance transport (GO:0071702),19
74,CAV3,regulation of cardiac muscle cell contraction (GO:0086004),19
75,CAV3,regulation of heart contraction (GO:0008016),19
76,CAV3,muscle organ development (GO:0007517),19
77,CAV3,regulation of calcium ion transmembrane transporter activity (GO:1901019),19
78,CAV3,negative regulation of kinase activity (GO:0033673),19
79,DMTN,regulation of peptidyl-threonine phosphorylation (GO:0010799),19
80,CAV3,regulation of calcium ion transmembrane transport (GO:1903169),19
81,CAV3,sterol homeostasis (GO:0055092),19
82,CAV3,regulation of cardiac muscle cell membrane repolarization (GO:0099623),19
83,RPSA,ribosome biogenesis (GO:0042254),18
84,RPSA,viral gene expression (GO:0019080),18
85,RPSA,rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),18
86,RPSA,ribosomal small subunit assembly (GO:0000028),18
87,RPSA,rRNA metabolic process (GO:0016072),18
88,RPSA,protein targeting to ER (GO:0045047),18
89,RPSA,ncRNA processing (GO:0034470),18
90,RPSA,rRNA transport (GO:0051029),18
91,RPSA,nuclear-transcribed mRNA catabolic process (GO:0000956),18
92,RPSA,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",18
93,RPSA,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",18
94,RPSA,cotranslational protein targeting to membrane (GO:0006613),18
95,RPSA,translation (GO:0006412),18
96,RPSA,peptide biosynthetic process (GO:0043043),18
97,RPSA,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),18
98,RPSA,rRNA processing (GO:0006364),18
99,RPSA,ribosome assembly (GO:0042255),18
100,RPSA,viral transcription (GO:0019083),18
101,RPL6,viral transcription (GO:0019083),16
102,RPL6,ribosome assembly (GO:0042255),16
103,RPL6,ribosomal large subunit assembly (GO:0000027),16
104,RPL6,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),16
105,RPL6,rRNA processing (GO:0006364),16
106,RPL6,viral gene expression (GO:0019080),16
107,RPL6,cytoplasmic translation (GO:0002181),16
108,RPL6,protein targeting to ER (GO:0045047),16
109,RPL6,peptide biosynthetic process (GO:0043043),16
110,RPL6,nuclear-transcribed mRNA catabolic process (GO:0000956),16
111,RPL6,cotranslational protein targeting to membrane (GO:0006613),16
112,RPL6,ribosomal large subunit biogenesis (GO:0042273),16
113,RPL6,ncRNA processing (GO:0034470),16
114,RPL6,translation (GO:0006412),16
115,RPL6,ribosome biogenesis (GO:0042254),16
116,RPL6,rRNA metabolic process (GO:0016072),16
117,ARHGAP35,regulation of cytoskeleton organization (GO:0051493),15
118,ARHGAP35,neuron projection fasciculation (GO:0106030),15
119,ARHGAP35,epiboly involved in wound healing (GO:0090505),15
120,ARHGAP35,regulation of actin polymerization or depolymerization (GO:0008064),15
121,ARHGAP35,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),15
122,THY1,negative regulation of neuron projection development (GO:0010977),15
123,THY1,negative regulation of kinase activity (GO:0033673),15
124,THY1,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),15
125,RPL10A,rRNA metabolic process (GO:0016072),15
126,RPL10A,peptide biosynthetic process (GO:0043043),15
127,THY1,regulation of axonogenesis (GO:0050770),15
128,RPL10A,ncRNA processing (GO:0034470),15
129,RPL10A,ribosomal large subunit biogenesis (GO:0042273),15
130,RPL10A,protein targeting to ER (GO:0045047),15
131,RPL10A,viral transcription (GO:0019083),15
132,THY1,regulation of T cell activation (GO:0050863),15
133,THY1,negative regulation of protein tyrosine kinase activity (GO:0061099),15
134,THY1,C-terminal protein amino acid modification (GO:0018410),15
135,THY1,positive regulation of adherens junction organization (GO:1903393),15
136,THY1,positive regulation of cell junction assembly (GO:1901890),15
137,ARHGAP35,positive regulation of cell projection organization (GO:0031346),15
138,ARHGAP35,regulation of cilium assembly (GO:1902017),15
139,THY1,regulation of release of sequestered calcium ion into cytosol (GO:0051279),15
140,THY1,positive regulation of focal adhesion assembly (GO:0051894),15
141,THY1,negative regulation of protein kinase activity (GO:0006469),15
142,THY1,negative regulation of cell motility (GO:2000146),15
143,THY1,regulation of protein tyrosine kinase activity (GO:0061097),15
144,RPL10A,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),15
145,RPL10A,rRNA processing (GO:0006364),15
146,ARHGAP35,axon development (GO:0061564),15
147,THY1,receptor clustering (GO:0043113),15
148,ARHGAP35,regulation of supramolecular fiber organization (GO:1902903),15
149,RPL23A,ribosome assembly (GO:0042255),15
150,RPL23A,peptide biosynthetic process (GO:0043043),15
151,RPL23A,ribosomal large subunit biogenesis (GO:0042273),15
152,RPL23A,cotranslational protein targeting to membrane (GO:0006613),15
153,RPL23A,ribosome biogenesis (GO:0042254),15
154,RPL23A,nuclear-transcribed mRNA catabolic process (GO:0000956),15
155,RPL23A,viral gene expression (GO:0019080),15
156,RPL23A,translation (GO:0006412),15
157,RPL23A,rRNA metabolic process (GO:0016072),15
158,RPL10A,maturation of LSU-rRNA (GO:0000470),15
159,RPL10A,cotranslational protein targeting to membrane (GO:0006613),15
160,RPL10A,ribosome biogenesis (GO:0042254),15
161,RPL10A,nuclear-transcribed mRNA catabolic process (GO:0000956),15
162,RPL10A,translation (GO:0006412),15
163,RPL10A,cytoplasmic translation (GO:0002181),15
164,RPL10A,viral gene expression (GO:0019080),15
165,ARHGAP35,positive regulation of cilium assembly (GO:0045724),15
166,RPL23A,ncRNA processing (GO:0034470),15
167,ARHGAP35,positive regulation of neuron projection development (GO:0010976),15
168,ARHGAP35,positive regulation of neuron differentiation (GO:0045666),15
169,RPL23A,viral transcription (GO:0019083),15
170,RPL23A,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),15
171,RPL23A,rRNA processing (GO:0006364),15
172,RPL23A,ribosomal large subunit assembly (GO:0000027),15
173,RPL23A,protein targeting to ER (GO:0045047),15
174,ARHGAP35,regulation of neuron projection development (GO:0010975),15
175,ARHGAP35,regulation of axonogenesis (GO:0050770),15
176,ARHGAP35,axonal fasciculation (GO:0007413),15
177,RPS7,rRNA processing (GO:0006364),14
178,CAMK2B,regulation of neuronal synaptic plasticity (GO:0048168),14
179,RPS7,viral gene expression (GO:0019080),14
180,RPS7,rRNA metabolic process (GO:0016072),14
181,RPS27,nuclear-transcribed mRNA catabolic process (GO:0000956),14
182,CAMK2B,regulation of dendritic spine development (GO:0060998),14
183,RPS27,rRNA metabolic process (GO:0016072),14
184,RPS27,protein targeting to ER (GO:0045047),14
185,RPS27,rRNA processing (GO:0006364),14
186,RPS27,viral gene expression (GO:0019080),14
187,RPS27,ribosomal small subunit assembly (GO:0000028),14
188,RPS27,translation (GO:0006412),14
189,RPS27,ribosome biogenesis (GO:0042254),14
190,RPS27,cotranslational protein targeting to membrane (GO:0006613),14
191,RPS27,peptide biosynthetic process (GO:0043043),14
192,RPS27,ncRNA processing (GO:0034470),14
193,RPS27,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),14
194,RPS7,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),14
195,RPS27,viral transcription (GO:0019083),14
196,RPS7,nuclear-transcribed mRNA catabolic process (GO:0000956),14
197,CAMK2B,regulation of metal ion transport (GO:0010959),14
198,CAMK2B,regulation of synapse maturation (GO:0090128),14
199,CAMK2B,positive regulation of nervous system development (GO:0051962),14
200,CAMK2B,positive regulation of cell projection organization (GO:0031346),14
201,CAMK2B,positive regulation of neuron differentiation (GO:0045666),14
202,CAMK2B,regulation of dendrite development (GO:0050773),14
203,RPS7,ncRNA processing (GO:0034470),14
204,RPS7,protein targeting to ER (GO:0045047),14
205,RPS7,peptide biosynthetic process (GO:0043043),14
206,RPS7,cotranslational protein targeting to membrane (GO:0006613),14
207,RPS7,ribosome biogenesis (GO:0042254),14
208,RPS7,negative regulation of ubiquitin-protein transferase activity (GO:0051444),14
209,RPS7,translation (GO:0006412),14
210,RPS7,cytoplasmic translation (GO:0002181),14
211,RPS7,viral transcription (GO:0019083),14
212,CAMK2B,regulation of synapse organization (GO:0050807),14
213,CAMK2B,regulation of long-term neuronal synaptic plasticity (GO:0048169),14
214,CAMK2B,positive regulation of dendritic spine development (GO:0060999),14
215,CAMK2B,regulation of neuron projection development (GO:0010975),14
216,CAMK2B,positive regulation of synapse maturation (GO:0090129),14
217,RPS27,ribosome assembly (GO:0042255),14
218,CAMK2B,positive regulation of neuron projection development (GO:0010976),14
219,RPS23,peptide biosynthetic process (GO:0043043),13
220,RPS23,rRNA metabolic process (GO:0016072),13
221,RPS23,ncRNA processing (GO:0034470),13
222,RPS23,viral transcription (GO:0019083),13
223,RPS23,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),13
224,RPS23,ribosome biogenesis (GO:0042254),13
225,RPS23,nuclear-transcribed mRNA catabolic process (GO:0000956),13
226,RPS23,translation (GO:0006412),13
227,RPS23,cytoplasmic translation (GO:0002181),13
228,RPS23,rRNA processing (GO:0006364),13
229,RPS23,cotranslational protein targeting to membrane (GO:0006613),13
230,RPS23,protein targeting to ER (GO:0045047),13
231,RPS23,viral gene expression (GO:0019080),13
232,RPL41,rRNA metabolic process (GO:0016072),13
233,RPL19,peptide biosynthetic process (GO:0043043),13
234,RPL19,viral transcription (GO:0019083),13
235,CACNG4,regulation of cation channel activity (GO:2001257),13
236,RPL19,protein targeting to ER (GO:0045047),13
237,RPL19,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),13
238,RPL41,nuclear-transcribed mRNA catabolic process (GO:0000956),13
239,RPL41,viral gene expression (GO:0019080),13
240,RPL41,cytoplasmic translation (GO:0002181),13
241,RPL41,translation (GO:0006412),13
242,RPL19,ribosome biogenesis (GO:0042254),13
243,RPL41,protein targeting to ER (GO:0045047),13
244,RPL41,rRNA processing (GO:0006364),13
245,RPL41,viral transcription (GO:0019083),13
246,RPL41,ncRNA processing (GO:0034470),13
247,RPL41,peptide biosynthetic process (GO:0043043),13
248,RPL41,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),13
249,RPL41,ribosome biogenesis (GO:0042254),13
250,RPL41,cotranslational protein targeting to membrane (GO:0006613),13
251,RPL19,cotranslational protein targeting to membrane (GO:0006613),13
252,RPL19,rRNA processing (GO:0006364),13
253,RPL19,ncRNA processing (GO:0034470),13
254,CACNG4,neurotransmitter receptor diffusion trapping (GO:0099628),13
255,CACNG4,positive regulation of synaptic transmission (GO:0050806),13
256,CACNG4,receptor localization to synapse (GO:0097120),13
257,CACNG4,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",13
258,CACNG4,regulation of AMPA receptor activity (GO:2000311),13
259,RPL19,rRNA metabolic process (GO:0016072),13
260,CACNG4,neurotransmitter receptor transport (GO:0099637),13
261,CACNG4,"neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)",13
262,CACNG4,membrane depolarization (GO:0051899),13
263,CACNG4,regulation of neurotransmitter receptor activity (GO:0099601),13
264,CACNG4,neurotransmitter receptor internalization (GO:0099590),13
265,CACNG4,regulation of glutamate receptor signaling pathway (GO:1900449),13
266,RPL19,viral gene expression (GO:0019080),13
267,RPL19,cytoplasmic translation (GO:0002181),13
268,RPL19,translation (GO:0006412),13
269,RPL19,nuclear-transcribed mRNA catabolic process (GO:0000956),13
270,CACNG4,postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),13
271,RPS15A,nuclear-transcribed mRNA catabolic process (GO:0000956),12
272,RPS15A,peptide biosynthetic process (GO:0043043),12
273,RPS15A,cotranslational protein targeting to membrane (GO:0006613),12
274,RPS15A,ribosome biogenesis (GO:0042254),12
275,RPS15A,protein targeting to ER (GO:0045047),12
276,RPS15A,viral transcription (GO:0019083),12
277,RPS15A,viral gene expression (GO:0019080),12
278,RPS15A,rRNA metabolic process (GO:0016072),12
279,RPS15A,rRNA processing (GO:0006364),12
280,RPS15A,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),12
281,KCNQ1,atrial cardiac muscle cell action potential (GO:0086014),12
282,RPS15A,ncRNA processing (GO:0034470),12
283,KCNQ1,cellular response to catecholamine stimulus (GO:0071870),12
284,RPS25,ribosome biogenesis (GO:0042254),12
285,KCNQ1,regulation of secretion (GO:0051046),12
286,RPS25,cotranslational protein targeting to membrane (GO:0006613),12
287,RPS25,peptide biosynthetic process (GO:0043043),12
288,RPS25,ncRNA processing (GO:0034470),12
289,RPS25,viral transcription (GO:0019083),12
290,KCNQ1,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),12
291,KCNQ1,heart contraction (GO:0060047),12
292,KCNQ1,regulation of cardiac muscle cell membrane repolarization (GO:0099623),12
293,KCNQ1,regulation of heart contraction (GO:0008016),12
294,RPS25,rRNA metabolic process (GO:0016072),12
295,RPS25,protein targeting to ER (GO:0045047),12
296,RPS25,viral gene expression (GO:0019080),12
297,RPS25,translation (GO:0006412),12
298,RPS25,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),12
299,RPS25,rRNA processing (GO:0006364),12
300,KCNQ1,positive regulation of cation transmembrane transport (GO:1904064),12
301,KCNQ1,positive regulation of potassium ion transport (GO:0043268),12
302,KCNQ1,response to cAMP (GO:0051591),12
303,KCNQ1,cellular response to cAMP (GO:0071320),12
304,KCNQ1,positive regulation of heart contraction (GO:0045823),12
305,RPS25,nuclear-transcribed mRNA catabolic process (GO:0000956),12
306,RPS15A,translation (GO:0006412),12
307,PKD1,lung development (GO:0030324),11
308,PLXNB1,regulation of axonogenesis (GO:0050770),11
309,PLXNB1,positive regulation of neuron projection development (GO:0010976),11
310,PLXNB1,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),11
311,PKD1,cytoplasmic sequestering of protein (GO:0051220),11
312,PLXNB1,regulation of osteoblast proliferation (GO:0033688),11
313,PKD1,negative regulation of transcription factor import into nucleus (GO:0042992),11
314,PKD1,detection of mechanical stimulus (GO:0050982),11
315,PKD1,mesonephric tubule development (GO:0072164),11
316,PKD1,skeletal system development (GO:0001501),11
317,PKD1,chordate embryonic development (GO:0043009),11
318,PKD1,connective tissue development (GO:0061448),11
319,PKD1,cytoplasmic sequestering of transcription factor (GO:0042994),11
320,PKD1,cartilage development (GO:0051216),11
321,PKD1,in utero embryonic development (GO:0001701),11
322,PLXNB1,positive regulation of axonogenesis (GO:0050772),11
323,PLXNB1,regulation of cytoskeleton organization (GO:0051493),11
324,PLXNB1,semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),11
325,PLXNB1,neuron projection morphogenesis (GO:0048812),11
326,PLXNB1,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),11
327,PLXNB1,axon extension (GO:0048675),11
328,PLXNB1,semaphorin-plexin signaling pathway (GO:0071526),11
329,BAIAP2,regulation of actin cytoskeleton reorganization (GO:2000249),11
330,BAIAP2,regulation of cytoskeleton organization (GO:0051493),11
331,BAIAP2,axon development (GO:0061564),11
332,BAIAP2,positive regulation of supramolecular fiber organization (GO:1902905),11
333,BAIAP2,neuron projection morphogenesis (GO:0048812),11
334,BAIAP2,Fc-gamma receptor signaling pathway (GO:0038094),11
335,BAIAP2,positive regulation of cytoskeleton organization (GO:0051495),11
336,BAIAP2,Fc receptor mediated stimulatory signaling pathway (GO:0002431),11
337,BAIAP2,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),11
338,BAIAP2,vascular endothelial growth factor receptor signaling pathway (GO:0048010),11
339,BAIAP2,cell morphogenesis involved in neuron differentiation (GO:0048667),11
340,AGRN,acetylcholine receptor signaling pathway (GO:0095500),10
341,AGRN,positive regulation of synapse assembly (GO:0051965),10
342,AGRN,receptor clustering (GO:0043113),10
343,AGRN,neuronal ion channel clustering (GO:0045161),10
344,SYT17,positive regulation of dendrite extension (GO:1903861),10
345,AGRN,aminoglycan catabolic process (GO:0006026),10
346,AGRN,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),10
347,AGRN,positive regulation of developmental growth (GO:0048639),10
348,AGRN,aminoglycan biosynthetic process (GO:0006023),10
349,AGRN,aminoglycan metabolic process (GO:0006022),10
350,AGRN,regulation of filopodium assembly (GO:0051489),10
351,APOD,negative regulation of protein import into nucleus (GO:0042308),10
352,APOD,negative regulation of intracellular protein transport (GO:0090317),10
353,APOD,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),10
354,APOD,negative regulation of focal adhesion assembly (GO:0051895),10
355,APOD,response to axon injury (GO:0048678),10
356,APOD,negative regulation of cell-matrix adhesion (GO:0001953),10
357,APOD,regulation of protein import into nucleus (GO:0042306),10
358,APOD,axon regeneration (GO:0031103),10
359,APOD,negative regulation of cell junction assembly (GO:1901889),10
360,APOD,negative regulation of adherens junction organization (GO:1903392),10
361,SYT17,clathrin-dependent endocytosis (GO:0072583),10
362,SYT17,synaptic vesicle endocytosis (GO:0048488),10
363,SYT17,positive regulation of neuron projection development (GO:0010976),10
364,SYT17,synaptic vesicle recycling (GO:0036465),10
365,SYT17,positive regulation of developmental growth (GO:0048639),10
366,SYT17,regulation of calcium ion-dependent exocytosis (GO:0017158),10
367,SYT17,regulation of dendrite extension (GO:1903859),10
368,SYT17,vesicle-mediated transport in synapse (GO:0099003),10
369,SYT17,regulation of regulated secretory pathway (GO:1903305),10
370,ARHGAP6,actin filament polymerization (GO:0030041),9
371,ARHGAP6,negative regulation of cell junction assembly (GO:1901889),9
372,ARHGAP6,actin polymerization or depolymerization (GO:0008154),9
373,ARHGAP6,negative regulation of focal adhesion assembly (GO:0051895),9
374,ARHGAP6,Rho protein signal transduction (GO:0007266),9
375,ARHGAP6,negative regulation of stress fiber assembly (GO:0051497),9
376,ARHGAP6,negative regulation of cell-matrix adhesion (GO:0001953),9
377,ARHGAP6,negative regulation of actin filament bundle assembly (GO:0032232),9
378,ARHGAP6,negative regulation of adherens junction organization (GO:1903392),9
379,HSP90AB1,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),8
380,HSP90AB1,Fc-gamma receptor signaling pathway (GO:0038094),8
381,HSP90AB1,positive regulation of phosphatase activity (GO:0010922),8
382,HSP90AB1,positive regulation of nitric oxide metabolic process (GO:1904407),8
383,HSP90AB1,negative regulation of cell cycle arrest (GO:0071157),8
384,LRP4,negative regulation of neuron projection development (GO:0010977),8
385,RUNX1,cartilage development (GO:0051216),8
386,RUNX1,positive regulation of interleukin-2 production (GO:0032743),8
387,LRP4,cell morphogenesis involved in neuron differentiation (GO:0048667),8
388,LRP4,neuromuscular junction development (GO:0007528),8
389,LRP4,neuron projection morphogenesis (GO:0048812),8
390,RUNX1,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),8
391,RUNX1,regulation of T cell differentiation (GO:0045580),8
392,HSP90AB1,Fc receptor mediated stimulatory signaling pathway (GO:0002431),8
393,RUNX1,regulation of interleukin-2 production (GO:0032663),8
394,RUNX1,regulation of response to cytokine stimulus (GO:0060759),8
395,RUNX1,regulation of bicellular tight junction assembly (GO:2000810),8
396,HSP90AB1,positive regulation of nitric oxide biosynthetic process (GO:0045429),8
397,RUNX1,regulation of cell junction assembly (GO:1901888),8
398,HSP90AB1,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),8
399,PALM,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),8
400,PALM,negative regulation of lyase activity (GO:0051350),8
401,LRP4,receptor clustering (GO:0043113),8
402,PALM,negative regulation of cAMP biosynthetic process (GO:0030818),8
403,PALM,regulation of filopodium assembly (GO:0051489),8
404,PALM,negative regulation of cyclase activity (GO:0031280),8
405,PALM,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),8
406,PALM,regulation of adenylate cyclase activity (GO:0045761),8
407,PALM,negative regulation of adenylate cyclase activity (GO:0007194),8
408,LRP4,presynaptic membrane assembly (GO:0097105),8
409,LRP4,presynapse assembly (GO:0099054),8
410,LRP4,regulation of axonogenesis (GO:0050770),8
411,SYN1,regulation of synaptic vesicle cycle (GO:0098693),7
412,ATP1A3,neuron projection organization (GO:0106027),7
413,NDUFB9,mitochondrial respiratory chain complex I biogenesis (GO:0097031),7
414,NDUFB9,mitochondrial respiratory chain complex I assembly (GO:0032981),7
415,NDUFB9,respiratory electron transport chain (GO:0022904),7
416,NDUFB9,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",7
417,NDUFB9,mitochondrial respiratory chain complex assembly (GO:0033108),7
418,ATP1A3,regulation of heart contraction (GO:0008016),7
419,ATP1A3,cellular response to amyloid-beta (GO:1904646),7
420,ATP1A3,regulation of cardiac conduction (GO:1903779),7
421,ATP1A3,neuron projection maintenance (GO:1990535),7
422,ATP1A3,cellular potassium ion homeostasis (GO:0030007),7
423,ATP1A3,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),7
424,SYN1,chemical synaptic transmission (GO:0007268),7
425,NDUFB9,mitochondrial ATP synthesis coupled electron transport (GO:0042775),7
426,NDUFB9,NADH dehydrogenase complex assembly (GO:0010257),7
427,NDUFA12,mitochondrial ATP synthesis coupled electron transport (GO:0042775),7
428,NDUFA12,NADH dehydrogenase complex assembly (GO:0010257),7
429,NDUFA12,mitochondrial respiratory chain complex I biogenesis (GO:0097031),7
430,NDUFA12,mitochondrial respiratory chain complex I assembly (GO:0032981),7
431,NDUFA12,respiratory electron transport chain (GO:0022904),7
432,NDUFA12,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",7
433,NDUFA12,mitochondrial respiratory chain complex assembly (GO:0033108),7
434,SYN1,regulation of synaptic vesicle transport (GO:1902803),7
435,SYN1,regulation of secretion by cell (GO:1903530),7
436,SYN1,regulation of calcium ion-dependent exocytosis (GO:0017158),7
437,SYN1,regulation of neurotransmitter transport (GO:0051588),7
438,SYN1,regulation of cellular localization (GO:0060341),7
439,RAPGEF3,endothelial cell development (GO:0001885),7
440,RAPGEF3,positive regulation of stress fiber assembly (GO:0051496),7
441,RAPGEF3,establishment of endothelial barrier (GO:0061028),7
442,RAPGEF3,response to cAMP (GO:0051591),7
443,RAPGEF3,cellular response to cAMP (GO:0071320),7
444,RAPGEF3,positive regulation of actin filament bundle assembly (GO:0032233),7
445,RAPGEF3,regulation of actin cytoskeleton reorganization (GO:2000249),7
446,PER1,regulation of metal ion transport (GO:0010959),6
447,SLIT1,cell morphogenesis involved in neuron differentiation (GO:0048667),6
448,SLIT1,neuron projection morphogenesis (GO:0048812),6
449,SLIT1,regulation of synapse assembly (GO:0051963),6
450,SLIT1,axon development (GO:0061564),6
451,PER1,negative regulation of JNK cascade (GO:0046329),6
452,SLIT1,motor neuron axon guidance (GO:0008045),6
453,PER1,histone deacetylation (GO:0016575),6
454,SRCIN1,regulation of dendritic spine development (GO:0060998),6
455,PER1,entrainment of circadian clock by photoperiod (GO:0043153),6
456,PER1,negative regulation of stress-activated MAPK cascade (GO:0032873),6
457,SRCIN1,negative regulation of protein tyrosine kinase activity (GO:0061099),6
458,SLIT1,axon extension (GO:0048675),6
459,SRCIN1,negative regulation of protein kinase activity (GO:0006469),6
460,SRCIN1,positive regulation of protein tyrosine kinase activity (GO:0061098),6
461,SRCIN1,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),6
462,PER1,histone H3 deacetylation (GO:0070932),6
463,SRCIN1,regulation of protein tyrosine kinase activity (GO:0061097),6
464,RAB11A,mitotic sister chromatid segregation (GO:0000070),5
465,GNAS,skeletal system development (GO:0001501),5
466,SYT7,synaptic vesicle cycle (GO:0099504),5
467,RAB11A,melanosome transport (GO:0032402),5
468,NAPA,chemical synaptic transmission (GO:0007268),5
469,NAPA,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",5
470,NAPA,COPII-coated vesicle budding (GO:0090114),5
471,NAPA,COPII vesicle coating (GO:0048208),5
472,NAPA,vesicle coating (GO:0006901),5
473,SYT7,regulation of regulated secretory pathway (GO:1903305),5
474,CSNK1E,rRNA metabolic process (GO:0016072),5
475,CSNK1E,rRNA processing (GO:0006364),5
476,CSNK1E,ncRNA processing (GO:0034470),5
477,CSNK1E,ribosome biogenesis (GO:0042254),5
478,ADGRL1,positive regulation of nervous system development (GO:0051962),5
479,ADGRL1,calcium-mediated signaling (GO:0019722),5
480,ADGRL1,regulation of synapse maturation (GO:0090128),5
481,ADGRL1,positive regulation of synapse maturation (GO:0090129),5
482,ADGRL1,calcium-mediated signaling using intracellular calcium source (GO:0035584),5
483,SYT7,regulation of calcium ion-dependent exocytosis (GO:0017158),5
484,B2M,response to iron ion (GO:0010039),5
485,GNAS,dopamine receptor signaling pathway (GO:0007212),5
486,GNAS,homotypic cell-cell adhesion (GO:0034109),5
487,RAB11A,renal water homeostasis (GO:0003091),5
488,RAB11A,pigment granule transport (GO:0051904),5
489,SLC8A2,regulation of cardiac conduction (GO:1903779),5
490,SLC8A2,regulation of short-term neuronal synaptic plasticity (GO:0048172),5
491,B2M,positive regulation of T cell cytokine production (GO:0002726),5
492,B2M,regulation of T cell cytokine production (GO:0002724),5
493,B2M,positive regulation of cytokine production involved in immune response (GO:0002720),5
494,B2M,positive regulation of T cell mediated immunity (GO:0002711),5
495,SLC8A2,positive regulation of synaptic transmission (GO:0050806),5
496,SLC8A2,regulation of neuronal synaptic plasticity (GO:0048168),5
497,CSNK1E,regulation of cellular localization (GO:0060341),5
498,SYT7,plasma membrane organization (GO:0007009),5
499,RAB11A,astral microtubule organization (GO:0030953),5
500,SLC8A2,regulation of heart contraction (GO:0008016),5
501,SYT7,synaptic vesicle recycling (GO:0036465),5
502,GNAS,platelet aggregation (GO:0070527),5
503,GNAS,bone development (GO:0060348),5
504,SLC25A29,cation transport (GO:0006812),4
505,SLC25A29,cation transmembrane transport (GO:0098655),4
506,SLC25A29,amino acid transport (GO:0006865),4
507,SLC6A7,neutral amino acid transport (GO:0015804),4
508,SLC25A29,nitrogen compound transport (GO:0071705),4
509,SEMA4A,regulation of axon extension involved in axon guidance (GO:0048841),4
510,SEMA4A,semaphorin-plexin signaling pathway (GO:0071526),4
511,SEMA4A,ameboidal-type cell migration (GO:0001667),4
512,SLC6A7,cation transmembrane transport (GO:0098655),4
513,SEMA4A,neural crest cell development (GO:0014032),4
514,NTNG2,C-terminal protein amino acid modification (GO:0018410),4
515,RPP38,ribosome biogenesis (GO:0042254),4
516,CPNE5,positive regulation of dendrite extension (GO:1903861),4
517,CPNE5,regulation of dendrite extension (GO:1903859),4
518,DDX56,ribosome biogenesis (GO:0042254),4
519,DDX56,ncRNA processing (GO:0034470),4
520,DDX56,rRNA processing (GO:0006364),4
521,DDX56,rRNA metabolic process (GO:0016072),4
522,DEF8,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),4
523,DEF8,regulation of bone resorption (GO:0045124),4
524,DEF8,positive regulation of bone resorption (GO:0045780),4
525,DEF8,positive regulation of bone remodeling (GO:0046852),4
526,RPP38,rRNA metabolic process (GO:0016072),4
527,GPSM2,establishment of mitotic spindle orientation (GO:0000132),4
528,GPSM2,positive regulation of cytoskeleton organization (GO:0051495),4
529,GPSM2,regulation of protein localization to cell cortex (GO:1904776),4
530,IL7,cellular response to interleukin-7 (GO:0098761),4
531,IL7,interleukin-7-mediated signaling pathway (GO:0038111),4
532,CPNE5,positive regulation of developmental growth (GO:0048639),4
533,CPNE5,positive regulation of neuron projection development (GO:0010976),4
534,IL7,regulation of T cell differentiation (GO:0045580),4
535,TUBB4A,regulation of microtubule polymerization (GO:0031113),4
536,TYRO3,negative regulation of innate immune response (GO:0045824),4
537,TYRO3,platelet aggregation (GO:0070527),4
538,TYRO3,phosphatidylinositol-mediated signaling (GO:0048015),4
539,TYRO3,homotypic cell-cell adhesion (GO:0034109),4
540,TUBB4A,negative regulation of microtubule polymerization or depolymerization (GO:0031111),4
541,BIN1,negative regulation of amyloid precursor protein catabolic process (GO:1902992),4
542,BIN1,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),4
543,BIN1,negative regulation of amyloid-beta formation (GO:1902430),4
544,BIN1,positive regulation of glial cell differentiation (GO:0045687),4
545,TUBB4A,negative regulation of protein polymerization (GO:0032272),4
546,TUBB4A,negative regulation of microtubule polymerization (GO:0031115),4
547,CACNA1A,membrane depolarization (GO:0051899),4
548,CACNA1A,cellular response to amyloid-beta (GO:1904646),4
549,CACNA1A,regulation of cytosolic calcium ion concentration (GO:0051480),4
550,CACNA1A,chemical synaptic transmission (GO:0007268),4
551,IL7,positive regulation of cytokine-mediated signaling pathway (GO:0001961),4
552,GPSM2,establishment of mitotic spindle localization (GO:0040001),4
553,PLP1,gliogenesis (GO:0042063),4
554,PLP1,axon development (GO:0061564),4
555,NRXN2,protein localization to synapse (GO:0035418),4
556,NTNG2,cell morphogenesis involved in neuron differentiation (GO:0048667),4
557,NTNG2,axon development (GO:0061564),4
558,SLC6A7,cation transport (GO:0006812),4
559,NTNG2,neuron projection morphogenesis (GO:0048812),4
560,PLP1,chemical synaptic transmission (GO:0007268),4
561,PLP1,substantia nigra development (GO:0021762),4
562,NRXN2,chemical synaptic transmission (GO:0007268),4
563,PPP1R9B,cellular response to ammonium ion (GO:0071242),4
564,PPP1R9B,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),4
565,PPP1R9B,calcium-mediated signaling (GO:0019722),4
566,PPP1R9B,second-messenger-mediated signaling (GO:0019932),4
567,RPP38,rRNA processing (GO:0006364),4
568,RPP38,ncRNA processing (GO:0034470),4
569,NRXN2,receptor clustering (GO:0043113),4
570,SLC6A7,proline transport (GO:0015824),4
571,NRXN2,postsynaptic density assembly (GO:0097107),4
572,HPCA,regulation of calcium ion transmembrane transporter activity (GO:1901019),3
573,PRKG1,negative regulation of vascular smooth muscle cell proliferation (GO:1904706),3
574,HPCA,regulation of voltage-gated calcium channel activity (GO:1901385),3
575,KNDC1,regulation of neuron projection development (GO:0010975),3
576,KNDC1,cell differentiation in hindbrain (GO:0021533),3
577,LARP1,cellular response to alcohol (GO:0097306),3
578,LARP1,TORC1 signaling (GO:0038202),3
579,PPP2R1A,nuclear-transcribed mRNA catabolic process (GO:0000956),3
580,PPP2R1A,second-messenger-mediated signaling (GO:0019932),3
581,PPP2R1A,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),3
582,BCAR1,hepatocyte growth factor receptor signaling pathway (GO:0048012),3
583,BCAR1,vascular endothelial growth factor receptor signaling pathway (GO:0048010),3
584,BCAR1,cell chemotaxis (GO:0060326),3
585,PRKG1,negative regulation of smooth muscle cell migration (GO:0014912),3
586,PRKG1,regulation of vascular associated smooth muscle cell migration (GO:1904752),3
587,INSIG1,sterol homeostasis (GO:0055092),3
588,ARPP19,positive regulation of glucose transport (GO:0010828),3
589,ARPP19,positive regulation of glucose import (GO:0046326),3
590,ARPP19,regulation of glucose import (GO:0046324),3
591,LARP1,regulation of viral genome replication (GO:0045069),3
592,LRFN4,cell morphogenesis involved in neuron differentiation (GO:0048667),3
593,ALCAM,neuron projection morphogenesis (GO:0048812),3
594,ALCAM,axon extension (GO:0048675),3
595,ALCAM,retinal ganglion cell axon guidance (GO:0031290),3
596,SLC43A2,neutral amino acid transport (GO:0015804),3
597,SLC43A2,amino acid transport (GO:0006865),3
598,SLC43A2,nitrogen compound transport (GO:0071705),3
599,INSIG1,cholesterol homeostasis (GO:0042632),3
600,KNDC1,regulation of dendrite development (GO:0050773),3
601,CAMK2N1,negative regulation of protein kinase activity (GO:0006469),3
602,PABPC4,peptide biosynthetic process (GO:0043043),3
603,HPCA,regulation of cation channel activity (GO:2001257),3
604,MMD2,positive regulation of small GTPase mediated signal transduction (GO:0051057),3
605,GIT1,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),3
606,GIT1,ephrin receptor signaling pathway (GO:0048013),3
607,GIT1,regulation of ARF protein signal transduction (GO:0032012),3
608,DOCK5,regulation of vascular associated smooth muscle cell migration (GO:1904752),3
609,DOCK5,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),3
610,DOCK5,positive regulation of smooth muscle cell migration (GO:0014911),3
611,MMD2,positive regulation of Ras protein signal transduction (GO:0046579),3
612,CAMK2N1,regulation of cyclin-dependent protein kinase activity (GO:1904029),3
613,INSIG1,negative regulation of intracellular protein transport (GO:0090317),3
614,PABPC4,nucleobase-containing compound catabolic process (GO:0034655),3
615,MMD2,positive regulation of neuron differentiation (GO:0045666),3
616,PABPC4,translation (GO:0006412),3
617,PDE5A,purine ribonucleotide catabolic process (GO:0009154),3
618,CAMK2N1,negative regulation of kinase activity (GO:0033673),3
619,CAPZB,regulation of lamellipodium organization (GO:1902743),3
620,CAPZB,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),3
621,CAPZB,regulation of filopodium assembly (GO:0051489),3
622,PDE4A,purine ribonucleotide catabolic process (GO:0009154),3
623,LRFN4,neuron projection morphogenesis (GO:0048812),3
624,PDE5A,cyclic nucleotide catabolic process (GO:0009214),3
625,PDE5A,cGMP metabolic process (GO:0046068),3
626,PDE4A,cAMP metabolic process (GO:0046058),3
627,PDE4A,cyclic nucleotide catabolic process (GO:0009214),3
628,LRFN4,axon development (GO:0061564),3
629,SLC7A5,neutral amino acid transport (GO:0015804),2
630,SLC7A5,amino acid transport (GO:0006865),2
631,UBTF,termination of RNA polymerase I transcription (GO:0006363),2
632,UBTF,transcription elongation from RNA polymerase I promoter (GO:0006362),2
633,WDR74,ribosomal large subunit biogenesis (GO:0042273),2
634,WDR74,ribosome biogenesis (GO:0042254),2
635,ZER1,regulation of transferase activity (GO:0051338),2
636,ZER1,regulation of ubiquitin-protein transferase activity (GO:0051438),2
637,SLC17A7,chemical synaptic transmission (GO:0007268),2
638,FASTKD2,cellular respiration (GO:0045333),2
639,NSMF,regulation of dendrite development (GO:0050773),2
640,MAPK11,cellular response to virus (GO:0098586),2
641,MAPK11,vascular endothelial growth factor receptor signaling pathway (GO:0048010),2
642,MAP2K2,regulation of cytoplasmic transport (GO:1903649),2
643,MAP2K2,ERK1 and ERK2 cascade (GO:0070371),2
644,LPAR6,positive regulation of Ras protein signal transduction (GO:0046579),2
645,LPAR6,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),2
646,HHIP,skeletal system morphogenesis (GO:0048705),2
647,FASTKD2,ribosomal large subunit assembly (GO:0000027),2
648,PCYT2,phosphatidylethanolamine metabolic process (GO:0046337),2
649,DDRGK1,positive regulation of transcription regulatory region DNA binding (GO:2000679),2
650,DDRGK1,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),2
651,DCLRE1C,telomere capping (GO:0016233),2
652,DCLRE1C,double-strand break repair via nonhomologous end joining (GO:0006303),2
653,CEP290,positive regulation of intracellular transport (GO:0032388),2
654,CEP290,regulation of establishment of protein localization (GO:0070201),2
655,AJAP1,negative regulation of response to wounding (GO:1903035),2
656,AJAP1,negative regulation of cell-matrix adhesion (GO:0001953),2
657,NSMF,regulation of neuronal synaptic plasticity (GO:0048168),2
658,HHIP,skeletal system development (GO:0001501),2
659,PCYT2,phosphatidylethanolamine biosynthetic process (GO:0006646),2
660,SLC17A7,synaptic vesicle cycle (GO:0099504),2
661,PIAS4,positive regulation of protein sumoylation (GO:0033235),2
662,PIAS4,double-strand break repair via nonhomologous end joining (GO:0006303),2
663,PPFIA3,regulation of neuronal synaptic plasticity (GO:0048168),2
664,RPH3A,regulation of regulated secretory pathway (GO:1903305),2
665,RPH3A,regulation of calcium ion-dependent exocytosis (GO:0017158),2
666,PPFIA3,regulation of short-term neuronal synaptic plasticity (GO:0048172),2
667,ST18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1
668,CELF1,posttranscriptional gene silencing by RNA (GO:0035194),1
669,CYP3A5,organonitrogen compound catabolic process (GO:1901565),1
670,CRTC1,entrainment of circadian clock by photoperiod (GO:0043153),1
671,CRKL,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1
672,CIRBP,positive regulation of translation (GO:0045727),1
673,TIMP3,regulation of membrane protein ectodomain proteolysis (GO:0051043),1
674,TOM1L1,negative regulation of mitotic cell cycle (GO:0045930),1
675,BSG,extracellular matrix disassembly (GO:0022617),1
676,CA1,bicarbonate transport (GO:0015701),1
677,RAB40C,regulation of secretion by cell (GO:1903530),1
678,B3GAT2,aminoglycan metabolic process (GO:0006022),1
679,ATN1,neuron apoptotic process (GO:0051402),1
680,ASIC1,cellular response to pH (GO:0071467),1
681,APLP1,cellular response to catecholamine stimulus (GO:0071870),1
682,ANP32A,nuclear transport (GO:0051169),1
683,UBE2I,positive regulation of protein sumoylation (GO:0033235),1
684,ANGPT2,regulation of blood vessel endothelial cell migration (GO:0043535),1
685,SGTA,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1
686,AGAP3,regulation of ARF protein signal transduction (GO:0032012),1
687,ADAP1,regulation of ARF protein signal transduction (GO:0032012),1
688,RANGAP1,negative regulation of intracellular protein transport (GO:0090317),1
689,DNAJB2,negative regulation of inclusion body assembly (GO:0090084),1
690,PTPRN,cellular response to glucose stimulus (GO:0071333),1
691,KCNQ2,chemical synaptic transmission (GO:0007268),1
692,PI4KB,phosphatidylinositol-mediated signaling (GO:0048015),1
693,NCS1,regulation of neuron projection development (GO:0010975),1
694,MYO9B,Rho protein signal transduction (GO:0007266),1
695,MTA1,entrainment of circadian clock by photoperiod (GO:0043153),1
696,MGST1,prostaglandin biosynthetic process (GO:0001516),1
697,ACTN4,regulation of NIK/NF-kappaB signaling (GO:1901222),1
698,PKD2L2,detection of mechanical stimulus (GO:0050982),1
699,PODXL2,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),1
700,POLE2,DNA replication initiation (GO:0006270),1
701,KDM5C,histone lysine demethylation (GO:0070076),1
702,JUND,response to cAMP (GO:0051591),1
703,PTGES2,prostaglandin biosynthetic process (GO:0001516),1
704,ITGA7,muscle organ development (GO:0007517),1
705,SLC6A8,amino acid transport (GO:0006865),1
706,GRIK5,chemical synaptic transmission (GO:0007268),1
707,GNAO1,dopamine receptor signaling pathway (GO:0007212),1
708,FN1,extracellular matrix disassembly (GO:0022617),1
709,TAC1,regulation of cytosolic calcium ion concentration (GO:0051480),1
710,TF,response to iron ion (GO:0010039),1
711,PTGDS,prostaglandin biosynthetic process (GO:0001516),1
712,ENTPD2,nucleobase-containing compound catabolic process (GO:0034655),1
713,EEF1D,translation (GO:0006412),1
714,ACAP3,regulation of ARF protein signal transduction (GO:0032012),1
